wrote a commentary accompanying one study of the drug in the New England Journal of Medicine.Deeks said long-acting shots also give hope of reaching groups that have a hard time sticking to treatment, including people with mental illness or substance abuse problems.“There’s a great unmet need” that the shots may fill, he said.Separately, ViiV plans to seek approval for cabotegravir for HIV prevention.
Two recent studies found that cabotegravir shots every two months were better than daily Truvada pills for keeping uninfected people from catching the virus from an infected sex partner.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education.